Assessment of a combined testing strategy for detection of antibodies to human herpesvirus 8 (HHV-8) in persons with Kaposi's sarcoma, persons with asymptomatic HHV-8 infection, and persons at low risk for HHV-8 infection

J Clin Microbiol. 2002 Oct;40(10):3822-5. doi: 10.1128/JCM.40.10.3822-3825.2002.

Abstract

The performance of a human herpesvirus 8 (HHV-8) enzyme immunoassay (EIA) and selective subsequent use of an HHV-8 immunofluorescence assay (IFA) was tested in persons unlikely to be infected with HHV-8 and those who had HHV-8 detected in their saliva. The IFA was performed on samples within a range of EIA optical densities (0.15 to 0.35) where there was considerable overlap between HHV-8-infected and uninfected individuals. The sensitivity of the testing strategy was 88%, with a specificity of 97%.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antibodies, Viral / analysis*
  • Herpesviridae Infections / virology*
  • Herpesvirus 8, Human / immunology*
  • Herpesvirus 8, Human / isolation & purification
  • Humans
  • Immunoenzyme Techniques / methods
  • Risk Factors
  • Sarcoma, Kaposi / immunology
  • Sarcoma, Kaposi / virology*

Substances

  • Antibodies, Viral